Cambridge, United Kingdom

Suki Klair


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suki Klair - Innovator in Therapeutic Compounds

Introduction

Suki Klair is a notable inventor based in Cambridge, GB. With a focus on innovative therapeutic compounds, she has made significant contributions to the field of medical research, particularly concerning cancer treatment.

Latest Patents

Suki Klair holds one patent titled "9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H-1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors." This invention relates to certain tricyclic compounds that inhibit Checkpoint Kinase 1 (CHK1) activity. These compounds have applications in pharmaceutical compositions aimed at treating diseases and conditions mediated by CHK1, including various proliferative conditions such as cancer.

Career Highlights

Suki Klair is currently associated with Cancer Research Technology Limited, where she plays a pivotal role in the development of new therapeutic strategies. Her innovative work has paved the way for advancements in cancer treatment options, enhancing the efficacy of existing therapies.

Collaborations

Throughout her career, Suki has collaborated with esteemed colleagues such as Ian James Collins and John Charles Reader. These partnerships have facilitated the exchange of ideas and expertise, further enriching her contributions to the scientific community.

Conclusion

In conclusion, Suki Klair is a forward-thinking inventor whose work in developing CHK1 kinase function inhibitors promises to make a significant impact in the field of oncology. Her dedication to advancing therapeutic compounds highlights the importance of innovation in the fight against cancer and other proliferative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…